COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹825 Cr | ₹86 Cr | ₹72 Cr | ₹92 Cr | ₹74 Cr |
What is the latest Total Non-Current Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹825 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹74 Cr |
How is Total Non-Current Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹825 Cr | 859.40 | |
| Mar2024 | ₹86 Cr | 19.83 | |
| Mar2023 | ₹72 Cr | -22.06 | |
| Mar2022 | ₹92 Cr | 24.63 | |
| Mar2021 | ₹74 Cr | - | |
Compare Total Non-Current Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,521.2 Cr | 12.9% | 5.4% | -53.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 12.9% |
5.4% |
-53.3% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses